Identification

Brand Name
Humira
Product Description
Humira is a prescription tumor necrosis factor (TNF) blocker available in multiple countries including the United States, Canada, the EU, Italy, and Indonesia. It was first marketed in 2002. It is available in a Subcutaneous Injection. It contains one active ingredient: Adalimumab. Adalimumab is a medication used to treat a wide variety of inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis.
Ingredients
DrugSalt
AdalimumabNot Available

Pharmacology

Indications
Management of Ankylosing Spondylitis (AS) Prescription
Management of Moderate to Severe Rheumatoid Arthritis Prescription
Management of Polyarticular Juvenile Idiopathic Arthritis Prescription
Management of Psoriatic Arthritis Prescription
Treatment of Hidradenitis Suppurativa (HS) Prescription
Treatment of Moderate to Severe Chronic Plaque Psoriasis Prescription
Treatment of Moderately to Severely Active Crohn's Disease Prescription
Treatment of Moderately to Severely Active Ulcerative Colitis Prescription
Treatment of Non-infectious Intermediate, Posterior and Panuveitis Prescription
Treatment of Pyoderma Gangrenosum Off Label
Used in combination for prophylaxis of Rejection Acute Renal in a regimen Prescription
Used in combination to manage Rejection Acute Renal in a regimen Prescription
Products
DosageStrengthRouteLabellerMarketing StartMarketing EndNDC Code
Injection, solution80 mgSubcutaneousAbb Vie Deutschland Gmb H Co. Kg2021-01-27-EU flag EU/1/03/256/021
Injection, solution40 mgSubcutaneousAbb Vie Deutschland Gmb H Co. Kg2016-09-08-EU flag EU/1/03/256/010
Injection, solution80 mgSubcutaneousAbb Vie Deutschland Gmb H Co. Kg2021-01-27-EU flag EU/1/03/256/026
Injection, solution40 mgSubcutaneousAbb Vie Deutschland Gmb H Co. Kg2016-09-08-EU flag EU/1/03/256/013
Injection, solution40 mgSubcutaneousAbb Vie Deutschland Gmb H Co. Kg2016-09-08-EU flag EU/1/03/256/019
Injection, solution40 mgSubcutaneousAbb Vie Deutschland Gmb H Co. Kg2016-09-08-EU flag EU/1/03/256/017
Injection, solution40 mgSubcutaneousAbb Vie Deutschland Gmb H Co. Kg2016-09-08-EU flag EU/1/03/256/004
Injection, solution40 mgSubcutaneousAbb Vie Deutschland Gmb H Co. Kg2016-09-08-EU flag EU/1/03/256/012
Injection, solution40 mgSubcutaneousAbb Vie Deutschland Gmb H Co. Kg2016-09-08-EU flag EU/1/03/256/006
Injection, solution80 mgSubcutaneousAbb Vie Deutschland Gmb H Co. Kg2021-01-27-EU flag EU/1/03/256/027
Injection, solution40 mgSubcutaneousAbb Vie Deutschland Gmb H Co. Kg2016-09-08-EU flag EU/1/03/256/018
Injection, solution40 mgSubcutaneousAbb Vie Deutschland Gmb H Co. Kg2016-09-08-EU flag EU/1/03/256/005
Injection, solution40 mgSubcutaneousAbb Vie Deutschland Gmb H Co. Kg2021-01-27-EU flag EU/1/03/256/024
Injection, solution40 mgSubcutaneousAbb Vie Deutschland Gmb H Co. Kg2021-01-27-EU flag EU/1/03/256/023
Injection, solution40 mg/0.8mlSubcutaneousAbb Vie Deutschland Gmb H Co. Kg2016-09-08-EU flag EU/1/03/256/001
Injection, solution40 mgSubcutaneousAbb Vie Deutschland Gmb H Co. Kg2016-09-08-EU flag EU/1/03/256/016
Injection, solution40 mgSubcutaneousAbb Vie Deutschland Gmb H Co. Kg2016-09-08-EU flag EU/1/03/256/003
Injection, solution40 mgSubcutaneousAbb Vie Deutschland Gmb H Co. Kg2021-01-27-EU flag EU/1/03/256/025
Injection, solution40 mgSubcutaneousAbb Vie Deutschland Gmb H Co. Kg2016-09-08-EU flag EU/1/03/256/009
Injection, solution40 mgSubcutaneousAbb Vie Deutschland Gmb H Co. Kg2016-09-08-EU flag EU/1/03/256/007
Injection, solution40 mgSubcutaneousAbb Vie Deutschland Gmb H Co. Kg2016-09-08-EU flag EU/1/03/256/014
Injection, solution40 mgSubcutaneousAbb Vie Deutschland Gmb H Co. Kg2016-09-08-EU flag EU/1/03/256/015
Injection, solution20 mgSubcutaneousAbb Vie Deutschland Gmb H Co. Kg2021-01-27-EU flag EU/1/03/256/022
Injection, solution40 mgSubcutaneousAbb Vie Deutschland Gmb H Co. Kg2016-09-08-EU flag EU/1/03/256/008
Injection, solution80 mgSubcutaneousAbb Vie Deutschland Gmb H Co. Kg2021-01-27-EU flag EU/1/03/256/020
Injection, solution40 mgSubcutaneousAbb Vie Deutschland Gmb H Co. Kg2016-09-08-EU flag EU/1/03/256/002
Solution10 mg / 0.1 mLSubcutaneousAbbvie--Canada flag 02474255
Solution40 mg / 0.4 mLSubcutaneousAbbvie2016-11-14-Canada flag 02458357
Solution40 mg / 0.8 mLSubcutaneousAbbvie2004-09-24-Canada flag 02258595
Solution80 mg / 0.8 mLSubcutaneousAbbvie--Canada flag 02466872
Solution40 mg / 0.4 mLSubcutaneousAbbvie2016-11-14-Canada flag 02458349
Solution80 mg / 0.8 mLSubcutaneousAbbvie--Canada flag 02474220
Solution20 mg / 0.2 mLSubcutaneousAbbvie2020-08-18-Canada flag 02474263
Injection, solution40 MG/0.8MLParenteral; SubcutaneousAbbvie Deutschland Gmbh & Co. Kg2014-07-08-Italy flag 035946019
Injection, solution40 MGParenteral; SubcutaneousAbbvie Deutschland Gmbh & Co. Kg2014-07-08-Italy flag 035946045
Injection, solution40 MGParenteral; SubcutaneousAbbvie Deutschland Gmbh & Co. Kg2014-07-08-Italy flag 035946084
Injection, solution40 MGParenteral; SubcutaneousAbbvie Deutschland Gmbh & Co. Kg2015-10-22-Italy flag 035946110
Injection, solution80 MGParenteral; SubcutaneousAbbvie Deutschland Gmbh & Co. Kg2017-11-18-Italy flag 035946197
Injection, solution40 MGParenteral; SubcutaneousAbbvie Deutschland Gmbh & Co. Kg2019-01-26-Italy flag 035946223
Injection, solution40 MGParenteral; SubcutaneousAbbvie Deutschland Gmbh & Co. Kg2016-10-04-Italy flag 035946173
Injection, solution40 MGParenteral; SubcutaneousAbbvie Deutschland Gmbh & Co. Kg2015-10-22-Italy flag 035946134
Injection, solution40 MGParenteral; SubcutaneousAbbvie Deutschland Gmbh & Co. Kg2014-07-08-Italy flag 035946060
Injection, solution80 MGParenteral; SubcutaneousAbbvie Deutschland Gmbh & Co. Kg2019-09-25-Italy flag 035946262
Injection, solution80 MGParenteral; SubcutaneousAbbvie Deutschland Gmbh & Co. Kg2019-01-26-Italy flag 035946250
Injection, solution40 MGParenteral; SubcutaneousAbbvie Deutschland Gmbh & Co. Kg2016-10-04-Italy flag 035946159
Injection, solution40 MGParenteral; SubcutaneousAbbvie Deutschland Gmbh & Co. Kg2019-01-26-Italy flag 035946247
Injection, solution40 MGParenteral; SubcutaneousAbbvie Deutschland Gmbh & Co. Kg2014-07-08-Italy flag 035946058
Injection, solution40 MGParenteral; SubcutaneousAbbvie Deutschland Gmbh & Co. Kg2019-01-26-Italy flag 035946235
Injection, solution40 MGParenteral; SubcutaneousAbbvie Deutschland Gmbh & Co. Kg2014-07-08-Italy flag 035946072
Injection, solution20 MGParenteral; SubcutaneousAbbvie Deutschland Gmbh & Co. Kg2018-09-08-Italy flag 035946211
Injection, solution40 MGParenteral; SubcutaneousAbbvie Deutschland Gmbh & Co. Kg2016-10-04-Italy flag 035946185
Injection, solution40 MGParenteral; SubcutaneousAbbvie Deutschland Gmbh & Co. Kg2014-07-08-Italy flag 035946033
Injection, solution40 MGParenteral; SubcutaneousAbbvie Deutschland Gmbh & Co. Kg2014-07-08-Italy flag 035946096
Injection, solution40 MGParenteral; SubcutaneousAbbvie Deutschland Gmbh & Co. Kg2014-07-08-Italy flag 035946108
Injection, solution40 MGParenteral; SubcutaneousAbbvie Deutschland Gmbh & Co. Kg2015-10-22-Italy flag 035946122
Injection, solution40 MGParenteral; SubcutaneousAbbvie Deutschland Gmbh & Co. Kg2014-07-08-Italy flag 035946021
Injection, solution80 MGParenteral; SubcutaneousAbbvie Deutschland Gmbh & Co. Kg2017-11-18-Italy flag 035946209
Injection, solution40 MGParenteral; SubcutaneousAbbvie Deutschland Gmbh & Co. Kg2015-10-22-Italy flag 035946146
Injection, solution40 MGParenteral; SubcutaneousAbbvie Deutschland Gmbh & Co. Kg2016-10-04-Italy flag 035946161
Injection40 MG/0.4MLSubcutaneousAbbott Indonesia2018-11-062023-11-06Indonesia flag DKI1882100643B2
Injection40 MG/0.4MLSubcutaneousAbbott Indonesia2018-10-172023-10-17Indonesia flag DKI1882100643B1
Injection, solution40 mg/0.8mLSubcutaneousAbbVie Inc.2002-12-302015-11-30US flag 0074-3797
InjectionSubcutaneousAbbott Indonesia2014-04-012019-10-30Indonesia flag DKI0582100643A1
InjectionSubcutaneousAbbott Indonesia2018-03-192024-06-12Indonesia flag DKI0582100643A2

Interactions